Other topics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
== Treatments == | |||
[[Enisamium_iodide|Enisamium iodide (Amizon)]] - drug profile. | |||
[[Larazotide_acetate|Larazotide acetate]] - experimental drug being trialed for MIS-C. | |||
[[Prife_iTeraCare_wand|Prife iTeraCare wand]] - Controversial medical device that was sold in the vaccine injured community through multi-level marketing. | |||
== Miscellaneous == | |||
[[Persecution_of_doctors_in_Ontario|Legal cases related to the persecution of doctors in Ontario]] | [[Persecution_of_doctors_in_Ontario|Legal cases related to the persecution of doctors in Ontario]] | ||
[[Vaccine_differences|Vaccine differences]] | [[Vaccine_differences|Vaccine differences]] | ||
Revision as of 04:02, 1 October 2023
Treatments
Enisamium iodide (Amizon) - drug profile. Larazotide acetate - experimental drug being trialed for MIS-C. Prife iTeraCare wand - Controversial medical device that was sold in the vaccine injured community through multi-level marketing.
Miscellaneous
Legal cases related to the persecution of doctors in Ontario